Background Multiple sclerosis (MS) is a chronic disease that affects the central nervous system and is characterized by inflammation, demyelination and degenerative changes (1). Approximately 85% of patients present with relapsing–remitting MS (RRMS), which is marked by recurrent relapses followed by partial recovery (1). Fingolimod (Gilenya) is th
694 Reached
Woman presented with Fever of Unknown Origin
7725 Reached93 Comments19 Likes
How Physicians Should Manage Stress?
35294 Reached152 Comments203 Likes
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Male with Jaw Pain and Abdominal Bloating
790 Reached24 Comments26 Likes
Case of Adolescent with Severe Macrocytic Anaemia
52855 Reached502 Comments51 Likes